These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 13536861)

  • 21. Indications for adrenergic stimulators in shock.
    Mills LC; Moyer JH
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
    [No Abstract]   [Full Text] [Related]  

  • 22. HEMODYNAMIC EFFECTS OF VASOPRESSOR AGENTS IN HEMORRHAGIC SHOCK.
    MILLS LC; STEPPACHER R
    Am J Cardiol; 1963 Nov; 12():614-8. PubMed ID: 14075986
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of shock with sympathicomimetic drugs. Use of metaraminol and comparison with other vasopressor agents.
    MILLS LC; VOUDOUKIS IJ; MOYER JH; HEIDER C
    Arch Intern Med; 1960 Dec; 106():816-23. PubMed ID: 13770952
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical aspects of shock. I. The effects of vasopressor agents in shock.
    Moyer JH; Mills LC
    R I Med J; 1966 Jan; 49(1):28-36. PubMed ID: 5216149
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of pressor agents in shock in myocardial infarction.
    GARAI O; SMITH KS
    Br Med J; 1958 Feb; 1(5065):247-51. PubMed ID: 13499913
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemodynamic effects of vasopressor agent (metaraminol) on hypotension in dogs produced by endotoxin.
    HINSHAW LB; MACLEAN LD; SPINK WW; VISSCHER MB; WEIL MH
    Proc Soc Exp Biol Med; 1956 Jul; 92(3):610-2. PubMed ID: 13359481
    [No Abstract]   [Full Text] [Related]  

  • 27. Ventricular function. V. The circulatory effects of aramine; mechanism of action of vasopressor drugs in cardiogenic shock.
    SARNOFF SJ; CASE RB; BERGLUND E; SARNOFF LC
    Circulation; 1954 Jul; 10(1):84-93. PubMed ID: 13172865
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical studies on a vasopressor agent: metaraminol (aramine). I. Observations in normotensive subjects.
    WEIL MH; SPINK WW
    Am J Med Sci; 1955 Jun; 229(6):661-9. PubMed ID: 14376394
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of severe acidosis on vasoactive effects of epinephrine and norepinephrine in human distal mammary artery.
    Vidal C; Grassin-Delyle S; Devillier P; Naline E; Lansac E; Ménasché P; Faisy C
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1698-705. PubMed ID: 24332106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressor amines and the carcinoid flush.
    LEVINE RJ; SJOERDSMA A
    Ann Intern Med; 1963 May; 58():818-28. PubMed ID: 13930167
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasopressor dose equivalence: A scoping review and suggested formula.
    Goradia S; Sardaneh AA; Narayan SW; Penm J; Patanwala AE
    J Crit Care; 2021 Feb; 61():233-240. PubMed ID: 33220576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Action of various analeptics on the kidney].
    Lareng L
    Anesth Analg (Paris); 1969; 26(5):707-10. PubMed ID: 4391673
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
    Levy B; Perez P; Perny J; Thivilier C; Gerard A
    Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac effects of isoproterenol, norepinephrine and epinephrine in complete A-V heart block during experimental acidosis and hyperkalemia.
    GUZMAN SV; DELEON AC; WEST JW; BELLET S
    Circ Res; 1959 Jul; 7(4):666-72. PubMed ID: 13663221
    [No Abstract]   [Full Text] [Related]  

  • 35. The treatment of cardiogenic shock. II. The use of pressor agents in the treatment of cardiogenic shock.
    Kuhn LA
    Am Heart J; 1967 Nov; 74(5):725-8. PubMed ID: 6055703
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of aramine as a pressor agent during spinal anesthesia.
    POE MF
    Anesthesiology; 1954 Sep; 15(5):547-50. PubMed ID: 13189164
    [No Abstract]   [Full Text] [Related]  

  • 37. The sympatho-adrenal factor in haemorrhagic shock.
    Irving MH
    Ann R Coll Surg Engl; 1968 Jun; 42(6):367-86. PubMed ID: 5654964
    [No Abstract]   [Full Text] [Related]  

  • 38. [Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock].
    Moret PR; Megevand R; Gemperle M
    Bibl Cardiol; 1966; 17():45-88. PubMed ID: 4287814
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vasopressor drugs in shock due to myocardial infarction].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1967 Oct; 22(45):1744-7. PubMed ID: 4294154
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study.
    Currigan DA; Hughes RJ; Wright CE; Angus JA; Soeding PF
    Anesthesiology; 2014 Nov; 121(5):930-6. PubMed ID: 25198173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.